AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 18708842 — intervention group
Group type: EXPERIMENTAL
Intervention: Toe sponges application for 3 weeks
Number of subjects: 24
Study 18708842 — intervention group
Group type: COMPARATOR
Intervention: Control group (no toe sponges)
Number of subjects: 24
Study 16779765 — intervention group
Group type: EXPERIMENTAL
Intervention: Playing mahjong twice a week (n = 33)
Number of subjects: 62
Study 16779765 — intervention group
Group type: EXPERIMENTAL
Intervention: Playing mahjong four times a week (n = 29)
Number of subjects: 62
Study 12707981 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine (3 g daily for 3 months)
Number of subjects: 15
Study 12707981 — intervention group
Group type: COMPARATOR
Intervention: Maltodextrin (placebo)
Number of subjects: 15
Study 10946888 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous GH treatment at 33 microg/kg x day
Number of subjects: 188
Study 10946888 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous GH treatment at 67 microg/kg x day
Number of subjects: 188
Study 10946888 — intervention group
Group type: EXPERIMENTAL
Intervention: Discontinuous GH treatment (average dose 32 microg/kg x day over 6 yr)
Number of subjects: 188
Study 10946888 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 188
Study 10946888 — intervention group
Group type: EXPERIMENTAL
Intervention: GH treatment
Number of subjects: 188
Study 8793161 — intervention group
Group type: EXPERIMENTAL
Intervention: Stable angina patients (male)
Number of subjects: 675
Study 8793161 — intervention group
Group type: EXPERIMENTAL
Intervention: Stable angina patients (female)
Number of subjects: 675
Study 8793161 — intervention group
Group type: EXPERIMENTAL
Intervention: Female patients with clinical heart failure
Number of subjects: 675
Study 8793161 — intervention group
Group type: EXPERIMENTAL
Intervention: Female patients without clinical heart failure
Number of subjects: 675
Study 8793161 — intervention group
Group type: COMPARATOR
Intervention: Controls
Number of subjects: 675
Study 8793161 — intervention group
Group type: EXPERIMENTAL
Intervention: Angina patients
Number of subjects: 675
Study 1451716 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril 50 mg b.d.
Number of subjects: 77
Study 1451716 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril 20 mg o.d.
Number of subjects: 77
Study 6207197 — intervention group
Group type: EXPERIMENTAL
Intervention: Antithyroid drug and T4 (group I)
Number of subjects: 21
Study 6207197 — intervention group
Group type: COMPARATOR
Intervention: β1‐selective adrenoreceptor blocking agent metoprolol (group II)
Number of subjects: 21
Study 6207197 — intervention group
Group type: COMPARATOR
Intervention: Euthyroid patients (group III)
Number of subjects: 21
Study 31638902 — intervention group
Group type: EXPERIMENTAL
Intervention: Namaste Care intervention
Number of subjects: 20
Study 30592442 — intervention group
Group type: EXPERIMENTAL
Intervention: Unskilled model observation combined with motor imagery training
Number of subjects: 36
Study 30592442 — intervention group
Group type: EXPERIMENTAL
Intervention: Skilled model observation combined with motor imagery training
Number of subjects: 36
Study 30592442 — intervention group
Group type: COMPARATOR
Intervention: Control group (reading a scientific paper)
Number of subjects: 36
Study 26970852 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial sialoadenectomy (PS)
Number of subjects: 31
Study 26970852 — intervention group
Group type: COMPARATOR
Intervention: Total sialoadenectomy (TS)
Number of subjects: 31
Study 26970852 — intervention group
Group type: EXPERIMENTAL
Intervention: Both PS and TS
Number of subjects: 31
Study 24621019 — intervention group
Group type: EXPERIMENTAL
Intervention: Peak wheelchair exercise test measuring POpeak (power output)
Number of subjects: 225
Study 24621019 — intervention group
Group type: EXPERIMENTAL
Intervention: Peak wheelchair exercise test measuring VO2peak (oxygen uptake)
Number of subjects: 225
Study 24621019 — intervention group
Group type: EXPERIMENTAL
Intervention: Life satisfaction measurement
Number of subjects: 225
Study 22196428 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Thai massage (TTM)
Number of subjects: 20
Study 22196428 — intervention group
Group type: COMPARATOR
Intervention: Physical therapy modalities (PT: ultrasound therapy and hot pack)
Number of subjects: 20
Study 20470840 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucrose sweetened soft drinks (4x25cl per day; 1800kJ)
Number of subjects: 53
Study 20470840 — intervention group
Group type: COMPARATOR
Intervention: Aspartame sweetened soft drinks (4x25cl per day; 67kJ)
Number of subjects: 53
Study 17909308 — intervention group
Group type: EXPERIMENTAL
Intervention: Selegiline ODT (1.25 mg/d for 6 weeks, then 2.5 mg/d for 6 weeks)
Number of subjects: 148
Study 17909308 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 148
Study 17909308 — intervention group
Group type: EXPERIMENTAL
Intervention: Selegiline ODT
Number of subjects: 148
Study 14979606 — intervention group
Group type: EXPERIMENTAL
Intervention: Vascor (test formulation of simvastatin 10 mg)
Number of subjects: 18
Study 14979606 — intervention group
Group type: COMPARATOR
Intervention: Commercially available preparation (reference formulation of simvastatin 10 mg)
Number of subjects: 18
Study 12201587 — intervention group
Group type: EXPERIMENTAL
Intervention: ARILVAX
Number of subjects: 1440
Study 12201587 — intervention group
Group type: COMPARATOR
Intervention: YF-VAX
Number of subjects: 1440
Study 12201587 — intervention group
Group type: EXPERIMENTAL
Intervention: Both vaccines
Number of subjects: 1440
Study 9524624 — intervention group
Group type: EXPERIMENTAL
Intervention: Povidone-iodine solution rinsing 4 times daily
Number of subjects: 40
Study 9524624 — intervention group
Group type: COMPARATOR
Intervention: Sterile water rinsing (Control)
Number of subjects: 40
Study 8590895 — intervention group
Group type: EXPERIMENTAL
Intervention: Liposomal melanoma vaccine combined with low-dose regional IL-2 (arm C)
Number of subjects: 24
Study 8590895 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose regional IL-2 only (arm D)
Number of subjects: 24
Study 8590895 — intervention group
Group type: COMPARATOR
Intervention: Liposomal melanoma vaccine alone (arm A)
Number of subjects: 24
Study 8590895 — intervention group
Group type: COMPARATOR
Intervention: Liposomal melanoma vaccine combined with systemic IL-2 (arm B)
Number of subjects: 24
Study 2666454 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem (120 mg bid to 180 mg bid)
Number of subjects: 96
Study 2666454 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96
Study 404027 — intervention group
Group type: COMPARATOR
Intervention: Extended field irradiation alone
Number of subjects: 74
Study 404027 — intervention group
Group type: EXPERIMENTAL
Intervention: Limited field irradiation followed by MOPP chemotherapy
Number of subjects: 74
Study 30636974 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital supply chain
Number of subjects: 57
Study 30636974 — intervention group
Group type: COMPARATOR
Intervention: Traditional supply chain
Number of subjects: 57
Study 30636974 — intervention group
Group type: EXPERIMENTAL
Intervention: Both supply chains
Number of subjects: 57
Study 30192681 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive hop‐to‐stabilization balance (PHSB) program
Number of subjects: 18
Study 30192681 — intervention group
Group type: COMPARATOR
Intervention: Single-limb balance (SLB) program
Number of subjects: 18
Study 26806185 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucosamine sulfate (1500mg once daily)
Number of subjects: 407
Study 26806185 — intervention group
Group type: COMPARATOR
Intervention: No DEP + placebo (Control)
Number of subjects: 407
Study 26806185 — intervention group
Group type: EXPERIMENTAL
Intervention: DEP + placebo (DEP)
Number of subjects: 407
Study 26806185 — intervention group
Group type: EXPERIMENTAL
Intervention: DEP + glucosamine sulfate (DEP + GS)
Number of subjects: 407
Study 26806185 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucosamine sulfate + no DEP (GS)
Number of subjects: 407
Study 25561135 — intervention group
Group type: EXPERIMENTAL
Intervention: Phlebodium decumanum (4 capsules of 400 mg/capsule, daily)
Number of subjects: 30
Study 25561135 — intervention group
Group type: EXPERIMENTAL
Intervention: Phlebodium decumanum (4 capsules of 400 mg/capsule, daily) plus coenzyme Q10 (4 capsules of 30 mg/capsule, daily)
Number of subjects: 30
Study 25561135 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 21844282 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive rehabilitation treatment (IRT) - 4 weeks of inpatient physical therapy including treadmill and stabilometric platform training.
Number of subjects: 50
Study 21844282 — intervention group
Group type: COMPARATOR
Intervention: Control group received only pharmacological treatment and was invited to practice generic physical exercise at home.
Number of subjects: 50
Study 20633256 — intervention group
Group type: COMPARATOR
Intervention: Education and advice session with a physiotherapist based on the content of the 'Back Book'
Number of subjects: 50
Study 20633256 — intervention group
Group type: EXPERIMENTAL
Intervention: Education and advice session plus a graded pedometer-driven walking programme prescribed by the physiotherapist
Number of subjects: 50
Study 17467956 — intervention group
Group type: EXPERIMENTAL
Intervention: Dihydrexidine (20 mg subcutaneously)
Number of subjects: 20
Study 17467956 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 15684319 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary counseling (regular foods)
Number of subjects: 111
Study 15684319 — intervention group
Group type: EXPERIMENTAL
Intervention: Protein supplements
Number of subjects: 111
Study 15684319 — intervention group
Group type: COMPARATOR
Intervention: Ad libitum intake
Number of subjects: 111
Study 12148107 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily short hemodialysis (DHD; six 2-hour sessions per week)
Number of subjects: 14
Study 10440307 — intervention group
Group type: EXPERIMENTAL
Intervention: ORS with reduced osmolarity
Number of subjects: 300
Study 10440307 — intervention group
Group type: COMPARATOR
Intervention: Standard WHO ORS
Number of subjects: 300
Study 8773035 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg Ginkgo biloba extract at 6 hourly intervals along with routine management
Number of subjects: 55
Study 8773035 — intervention group
Group type: COMPARATOR
Intervention: Placebo tablets of same size, shape and colour, given in the same way as Ginkgo biloba
Number of subjects: 55
Study 2405893 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal hyoscine (Scopoderm, Ciba‐Geigy)
Number of subjects: 283
Study 2405893 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 283
Study 6161281 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment modality (vitrectomy plus photocoagulation)
Number of subjects: 28
Study 6161281 — intervention group
Group type: COMPARATOR
Intervention: Sole application of photocoagulation
Number of subjects: 28
Study 30312457 — intervention group
Group type: EXPERIMENTAL
Intervention: Observed height
Number of subjects: 14676
Study 30312457 — intervention group
Group type: EXPERIMENTAL
Intervention: Height genetic score
Number of subjects: 14676
Study 30312457 — intervention group
Group type: EXPERIMENTAL
Intervention: Observed BMI
Number of subjects: 14676
Study 30312457 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI genetic score
Number of subjects: 14676
Study 27221151 — intervention group
Group type: EXPERIMENTAL
Intervention: Hibiscus sabdariffa (HS)
Number of subjects: 78
Study 27221151 — intervention group
Group type: EXPERIMENTAL
Intervention: lisinopril
Number of subjects: 78
Study 27221151 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 78
Study 26310300 — intervention group
Group type: COMPARATOR
Intervention: Point-to-point irrigated radiofrequency ablation (Conv)
Number of subjects: 50
Study 26310300 — intervention group
Group type: COMPARATOR
Intervention: Phased multipolar radiofrequency ablation (PMRA)
Number of subjects: 50
Study 26310300 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall success rate for zero AF recurrence at 12 months
Number of subjects: 50
Study 25218696 — intervention group
Group type: EXPERIMENTAL
Intervention: Nocturnal denture wear
Number of subjects: 70
Study 25218696 — intervention group
Group type: COMPARATOR
Intervention: No denture wear
Number of subjects: 70
Study 21975269 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormonal contraception (injectable and oral)
Number of subjects: 3790
Study 21975269 — intervention group
Group type: COMPARATOR
Intervention: No hormonal contraception
Number of subjects: 3790
Study 20216558 — intervention group
Group type: EXPERIMENTAL
Intervention: High-protein low-fat diet (HP-LF)
Number of subjects: 17
Study 20216558 — intervention group
Group type: COMPARATOR
Intervention: Low-protein high-fat diet (LP-HF)
Number of subjects: 17
Study 17924243 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based bipolar education program
Number of subjects: 8000
Study 15832145 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly physiotherapy
Number of subjects: 43
Study 15832145 — intervention group
Group type: COMPARATOR
Intervention: Control group (no physiotherapy)
Number of subjects: 43
Study 12077724 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-glycemic index breakfast (low-GIB)
Number of subjects: 13
Study 12077724 — intervention group
Group type: COMPARATOR
Intervention: High-glycemic index breakfast (high-GIB)
Number of subjects: 13
Study 10345258 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality improvement intervention to improve preventive services
Number of subjects: 647
Study 7881957 — intervention group
Group type: EXPERIMENTAL
Intervention: Graduated compression hosiery (various brands)
Number of subjects: 0
Study 7881957 — intervention group
Group type: EXPERIMENTAL
Intervention: Pneumatic thigh cuffs inflated to 20 mmHg
Number of subjects: 0
Study 7881957 — intervention group
Group type: EXPERIMENTAL
Intervention: Pneumatic thigh cuffs inflated to 40 mmHg
Number of subjects: 0
Study 7881957 — intervention group
Group type: EXPERIMENTAL
Intervention: Custom-made stockings with a profile of 16.8 mmHg at the ankle, 14.5 mmHg at the calf, and 6.4 mmHg at the upper thigh
Number of subjects: 0
Study 7881957 — intervention group
Group type: COMPARATOR
Intervention: Standard compression profile stockings (18 mmHg at the ankle, 14 mmHg at the calf, and 8 mmHg at the upper thigh)
Number of subjects: 0
Study 2194788 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenugreek seeds (100 g, divided into two doses during lunch and dinner)
Number of subjects: 0
Study 7393831 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous naloxone administration
Number of subjects: 0
Study 30292847 — intervention group
Group type: EXPERIMENTAL
Intervention: PET-CT
Number of subjects: 96
Study 30292847 — intervention group
Group type: COMPARATOR
Intervention: CE-CT
Number of subjects: 96
Study 29232438 — intervention group
Group type: COMPARATOR
Intervention: R-CHOP
Number of subjects: 297
Study 29232438 — intervention group
Group type: COMPARATOR
Intervention: CHOP without MYC translocations
Number of subjects: 297
Study 29232438 — intervention group
Group type: COMPARATOR
Intervention: CHOP with negative MYC-IHC
Number of subjects: 297
Study 29232438 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab as part of salvage therapy
Number of subjects: 297
Study 29232438 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab after first-line CHOP
Number of subjects: 297
Study 29232438 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab after R-CHOP
Number of subjects: 297
Study 26384447 — intervention group
Group type: EXPERIMENTAL
Intervention: TDV (various dosages including increased TDV-4 and one-tenth TDV dose)
Number of subjects: 140
Study 26384447 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 140
Study 23124684 — intervention group
Group type: EXPERIMENTAL
Intervention: Evidence-based supported employment
Number of subjects: 187
Study 23124684 — intervention group
Group type: COMPARATOR
Intervention: Diversified placement approach
Number of subjects: 187
Study 20840689 — intervention group
Group type: EXPERIMENTAL
Intervention: Scaling and root planing (SRP) plus oral hygiene instruction
Number of subjects: 322
Study 20840689 — intervention group
Group type: COMPARATOR
Intervention: Oral hygiene instruction only (control)
Number of subjects: 322
Study 20840689 — intervention group
Group type: EXPERIMENTAL
Intervention: Successful periodontal treatment
Number of subjects: 322
Study 20840689 — intervention group
Group type: EXPERIMENTAL
Intervention: Unsuccessful periodontal treatment
Number of subjects: 322
Study 19166685 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated leukocyte counts after primary PCI
Number of subjects: 363
Study 19166685 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated neutrophil counts after primary PCI
Number of subjects: 363
Study 17547876 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravaginal metronidazole gel
Number of subjects: 0
Study 17547876 — intervention group
Group type: COMPARATOR
Intervention: Observation group
Number of subjects: 0
Study 16389542 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg Delta(9)-tetrahydrocannabinol (dronabinol)
Number of subjects: 100
Study 16389542 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 12587799 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-aminopyridine (4-AP)
Number of subjects: 60
Study 10917981 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic-assisted abdominal aortic aneurysmectomy
Number of subjects: 60
Study 10917981 — intervention group
Group type: COMPARATOR
Intervention: Open transabdominal or retroperitoneal aneurysmectomy
Number of subjects: 60
Study 8806339 — intervention group
Group type: EXPERIMENTAL
Intervention: Active pectoral-pulse generator shell
Number of subjects: 21
Study 8806339 — intervention group
Group type: COMPARATOR
Intervention: Lead alone (control)
Number of subjects: 21
Study 1634627 — intervention group
Group type: EXPERIMENTAL
Intervention: Occlusal Adjustment (OA)
Number of subjects: 50
Study 1634627 — intervention group
Group type: COMPARATOR
Intervention: No Occlusal Adjustment (No OA)
Number of subjects: 50
Study 6480247 — intervention group
Group type: EXPERIMENTAL
Intervention: Conditioned emotional response established with a specific tone pattern followed by an aversive noise in the left ear.
Number of subjects: 0
Study 6480247 — intervention group
Group type: COMPARATOR
Intervention: Control subjects received noises presented at random times without a specific tone pattern.
Number of subjects: 0
Study 6480247 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental subjects on interpolated CS-alone trials.
Number of subjects: 0
Study 31199501 — intervention group
Group type: EXPERIMENTAL
Intervention: TP53 mutations
Number of subjects: 210
Study 31199501 — intervention group
Group type: EXPERIMENTAL
Intervention: TP53 and either KRAS or NRAS mutations
Number of subjects: 210
Study 31199501 — intervention group
Group type: COMPARATOR
Intervention: BRAF mutation
Number of subjects: 210
Study 31438908 — intervention group
Group type: EXPERIMENTAL
Intervention: Time-limited letter with pre-notification and reminder SMS
Number of subjects: 12244
Study 31438908 — intervention group
Group type: EXPERIMENTAL
Intervention: Open-ended letter with reminder SMS
Number of subjects: 12244
Study 31438908 — intervention group
Group type: EXPERIMENTAL
Intervention: Time-limited letter with reminder SMS
Number of subjects: 12244
Study 31438908 — intervention group
Group type: COMPARATOR
Intervention: Control letter without SMS
Number of subjects: 12244
Study 29166194 — intervention group
Group type: EXPERIMENTAL
Intervention: Music therapy
Number of subjects: 44
Study 29166194 — intervention group
Group type: COMPARATOR
Intervention: Control group (no music therapy)
Number of subjects: 44
Study 26939313 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture for warming yang and benefiting qi
Number of subjects: 180
Study 26939313 — intervention group
Group type: COMPARATOR
Intervention: Seretide (western medication)
Number of subjects: 180
Study 22907998 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic hypothermia (TH) with cooling gel packs to a target temperature of 33‐34°C for 72 h
Number of subjects: 116
Study 22907998 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic hypothermia (TH)
Number of subjects: 116
Study 22907998 — intervention group
Group type: COMPARATOR
Intervention: Normothermia (Control)
Number of subjects: 116
Study 21212385 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 Gy of radiation therapy (TE18 trial)
Number of subjects: 2466
Study 21212385 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboplatin (TE19 trial)
Number of subjects: 2466
Study 21212385 — intervention group
Group type: EXPERIMENTAL
Intervention: Para‐aortic radiation therapy (TE10 trial)
Number of subjects: 2466
Study 21212385 — intervention group
Group type: COMPARATOR
Intervention: Radiation therapy (TE19 trial)
Number of subjects: 2466
Study 18372441 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral anticoagulants
Number of subjects: 0
Study 18372441 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study 18372441 — intervention group
Group type: COMPARATOR
Intervention: Antiplatelet therapy
Number of subjects: 0
Study 16705841 — intervention group
Group type: EXPERIMENTAL
Intervention: Acu-moxibustion group (treated with filiform needle plus moxibustion)
Number of subjects: 480
Study 16705841 — intervention group
Group type: EXPERIMENTAL
Intervention: Basic treatment plus acu-moxibustion group (treated with oral medicine like those in the control group plus acupuncture and moxibustion)
Number of subjects: 480
Study 16705841 — intervention group
Group type: COMPARATOR
Intervention: Control group (treated with prednisone, vitamin B1, vitamin B12 and dibazol)
Number of subjects: 480
Study 15353914 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute normovolemic hemodilution (ANH)
Number of subjects: 71
Study 15353914 — intervention group
Group type: COMPARATOR
Intervention: No ANH
Number of subjects: 71
Study 11397789 — intervention group
Group type: EXPERIMENTAL
Intervention: Preeclampsia plasma
Number of subjects: 21
Study 11397789 — intervention group
Group type: COMPARATOR
Intervention: Normal pregnancy plasma
Number of subjects: 21
Study 11397789 — intervention group
Group type: COMPARATOR
Intervention: Nonpregnant women plasma
Number of subjects: 21
Study 9242312 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical signs and laboratory parameters (cold periphery, deep coma, hypoglycemia)
Number of subjects: 624
Study 9242312 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated urea levels on admission, multiple episodes of hypoglycemia, multiple convulsions
Number of subjects: 624